Industry and News Fidaxomicin Market Кликнуть для чтения
  • Комментарии

Industry and News

Fidaxomicin Market

Опубликовано в "Бизнес, Здоровье и фитнес", язык - English. 4 страниц.
Global Fidaxomicin Market is expected to grow at a significant CAGR in the upcoming years as the scope and its applications are rising enormously across the globe. Fidaxomicin is also termed as Difimicin, or Tiacumicin B, or Lipiarmicin, or Lipiarrmycin, or Lipiarmycin. It is a macrolide antibacterial drug specified for the treatment of Clostridium Difficile-Associated Diarrhea. The antibiotic Fidaxomicin drug kills bacteria in the intestines. Еще
Industry And News helps to understand the characteristics and preferences of customers and monitor the level of competition in market. Еще
Бесплатно

Другие публикации «Industry and News»

Посмотреть все публикации